secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0000950170-22-026227
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics amends Royalty Pharma loan, extends draw deadlines to Mar 31, 2023
-------------------------------------------------------------------------------

- Amendment extends deadline for Tranche 2 and Tranche 3 Term Loans from Dec 31, 2022 to Mar 31, 2023.
- Repayment amount for those tranches increased from 190% to 200% of principal as consideration.
- Original Loan Agreement provided up to $300M for omecamtiv mecarbil, aficamten, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017022026227/0000950170-22-026227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017022026227/cytk-20221208.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer